Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 990.44 Million | USD 1409.71 Million | 4% | 2023 |
The global Acetaminophen (Paracetamol) Market size was worth around USD 990.44 million in 2023 and is predicted to grow to around USD 1409.71 million by 2032 with a compound annual growth rate (CAGR) of roughly 4.00% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD million). The report covers a forecast and an analysis of the Acetaminophen (Paracetamol) Market on a global and regional level.
Acetaminophen (APAP) is commonly known as paracetamol is a drug used to treat fever (antipyretic) and pain (analgesic). It is classified as mild analgesic and is widely used for relief of mild to moderate intensity pain. For severe type of pain like pain after surgery, cancer pain etc. it is used in combination with opioid drugs. Acetaminophen is used in combination of cold medications to relieve fever in children. Paracetamol is mostly given orally or rectally, but it is also administered via intravenous route.
The demand for acetaminophen market is driven by increasing prevalence of chronic disorders and conditions requiring pain management. Also, it is widely available as an over the counter medicine in many countries and is being used as analgesic for treating mild to moderate pain. Increasing use of acetaminophen drives the market growth. However, availability of large number of generics and intense competition may restrain the market growth. Emerging markets with increasing geriatric population base are expected to bring new growth opportunities for major market players operating in the global acetaminophen market.
The study provides a crucial view on the acetaminophen by segmenting the market based on form, indication, route of administration and region. All the segments of acetaminophen market have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
Based on form, global acetaminophen market is bifurcated into tablet, liquid suspension, capsule, and other forms. Tablet form segment held largest market share in 2023 whereas liquid suspension segment is expected to register rapid CAGR over the forecast period.
Based on route of administration, global acetaminophen market is divided into oral, rectal and intravenous. The oral segment held major share of the market in 2023, however the rectal segment is likely to grow at high CAGR in the forecast period. Growing demand for over the counter and generic drugs is likely to drive the market for these segments. Besides, high population and availability of cheap oral paracetamols are other factors driving market growth of the oral acetaminophens.
Report Attributes | Report Details |
---|---|
Report Name | Acetaminophen (Paracetamol) Market |
Market Size in 2023 | USD 990.44 Million |
Market Forecast in 2032 | USD 1409.71 Million |
Growth Rate | CAGR of 4% |
Number of Pages | 110 |
Key Companies Covered | Genesis Biotech, M.M. Pharma, Aknil biotech, Arika healthcare, Captab biotech, and GlaxoSmithKline Pharmaceuticals Ltd. among others |
Segments Covered | By Form, By Route of Administration and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Asia Pacific dominated the global acetaminophen market in 2023. Easy availability of over the counter acetaminophen, increasing chronic disease burden, increasing need to manage pain, growing awareness are factors driving the market in this region. India and China are largest markets in Asia Pacific for acetaminophen. North America was second largest regional market followed by Europe. Latin America is another highly growing regional market. Argentina and Brazil are expected to drive the acetaminophen market over the forecast period. Increasing healthcare spending and availability of affordable drugs are factors attributing to the rapid growth in Latin America. Middle East and Africa will see noticeable growth in the coming years with growth majorly focused in GCC countries and South Africa.
Major players included in the report are:
Global Acetaminophen (Paracetamol) Market: By Form
Global Acetaminophen (Paracetamol) Market: By Route of Administration
Global Acetaminophen (Paracetamol) Market: By Region
FrequentlyAsked Questions
Acetaminophen (APAP) is commonly known as paracetamol is a drug used to treat fever (antipyretic) and pain (analgesic). It is classified as mild analgesic and is widely used for relief of mild to moderate intensity pain.
According to study, the Acetaminophen (Paracetamol) Market size was worth around USD 990.44 million in 2023 and is predicted to grow to around USD 1409.71 million by 2032.
The CAGR value of Acetaminophen (Paracetamol) Market is expected to be around 4.00% during 2024-2032.
Asia Pacific has been leading the Acetaminophen (Paracetamol) Market and is anticipated to continue on the dominant position in the years to come.
The Acetaminophen (Paracetamol) Market is led by players like Genesis Biotech, M.M. Pharma, Aknil biotech, Arika healthcare, Captab biotech, and GlaxoSmithKline Pharmaceuticals Ltd. among others.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed